ATRIOPEPTIN REGULATION AND RENAL-FUNCTION IN CONSCIOUS SPONTANEOUSLY HYPERTENSIVE RATS

被引：9

作者：

KOEPKE, JP

TYLER, LD

MEHTA, PP

OLINS, GM

TRAPANI, AJ

HARTUPEE, DA

BOVY, PR

SPEAR, KL

BLAINE, EH

机构：

[1] Searle Research and Development, Department of Pharmacology, Washington University School of Medicine, Monsanto Life Sciences Research Center, Searle Research and Development, MO, 700, St. Louis, Missouri, Chesterfield Village Parkway, hesterfield

来源：

AMERICAN JOURNAL OF HYPERTENSION | 1990年 / 3卷 / 08期

关键词：

Endopeptidase inhibitor; Hypertension; Non-guanylate cyclase-linked atriopeptin receptor ligand;

D O I：

10.1093/ajh/3.8.622

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

We examined the interaction of a non-guanylate cyclase-linked atriopeptin (AP) binding site ligand, SC-46542 (des[Phe106, Gly107, Ala115, Gln116]AP-(103-126)), and an endopeptidase 24.11 inhibitor, thiorphan, on mean arterial pressure, urinary sodium excretion, urinary cyclic guanosine monophosphate (cGMP) excretion, plasma cGMP concentration, and plasma AP immunoreactivity (ir) in conscious spontaneously hypertensive rats (SHR) and normo-tensive Wistar-Kyoto rats (WKY). Compared to vehicle control rats, coadministration of SC-46542 and thiorphan increased urinary sodium excretion in SHR from 2.1 ± 0.3 to 11.6 ± 0.7 μEq/min/100 g body weight and in WKY from 1.6 ± 0.4 to 4.4 ± 0.4 μEq/min/100 g body weight, and increased urinary cGMP excretion in SHR from 2.7 ± 0.5 to 79.0 ± 17.5 pmol/min/100 g body weight and in WKY from 7.0 ± 3.0 to 72.4 ± 10.6 pmol/min/100 g body weight. The change in urinary sodium excretion was greater in SHR than WKY. The coadministration of SC-46542 and thiorphan had greater effects on urinary sodium excretion and urinary cGMP excretion than administration of either compound alone. Coadministration of thiorphan and SC-46542 had no effect on glomerular filtration rate or plasma cGMP concentration, suggesting that the urinary cGMP excretion response was nephrogenous. Compared to vehicle control rats, plasma APir was increased during coadministration of SC-46542 and thiorphan in both SHR (998 ±76 ν 5.10 ± 116 pg/mL) and WKY (775 ± 36 v 414 ± 36 pg/mL). Mean arterial pressure was unaffected by SC-46542 and thiorphan in SHR or WKY. These results indicate that SC-46542 and thiorphan interact within the kidney to increase urinary sodium and cGMP excretion in conscious SHR and WKY. © 1990 by the American Journal of Hypertension, Ltd.

引用

页码：622 / 627

页数：6

共 22 条

[1]

Gee N.S., Bowes M.A., Buck P., Kenny A.J., An immunoradiometric assay for endopeptidase 24.11 shows it to be a widely distributed enzyme in pig tissues, Biochem J, 228, pp. 119-126, (1985)

[2]

Olins G.M., Spear K.L., Siegel N.R., Et al., Atrial peptide inactivation by rabbit-kidney brush-border membranes, Eur J Biochem, 170, pp. 431-434, (1987)

[3]

Shima M., Seino Y., Torikai S., Imai M., Intrarenal localization of degradation of atrial natriuretic peptide in isolated glomeruli and cortical nephron segments, Life Sci, 43, pp. 357-363, (1988)

[4]

Olins G.M., Krieter P.A., Trapani A.J., Et al., Specific inhibitors of endopeptidase 24.11 inhibit the metabolism of atrial natriuretic peptides in vitro and in vivo, Mol Cell Endocrinol, 61, pp. 201-208, (1988)

[5]

Maack T., Suzuki M., Almeida F.A., Et al., Physiological role of silent receptors of atrial natriuretic factor, Science, 238, pp. 675-678, (1987)

[6]

Leitman D.C., Andresen J.W., Kuno T., Et al., Identification of multiple binding sites for atrial natriuretic factor by affinity cross-linking in cultured endothelial cells, J Biol Chem, 261, pp. 11650-11655, (1986)

[7]

Scarborough R.M., Schenk D.B., McEnroe G.A., Et al., Truncated atrial natriuretic peptide analogs: comparison between receptor binding and stimulation of cyclic GMP accumulation in cultured vascular smooth muscle cells, J Biol Chem, 261, pp. 12960-12964, (1986)

[8]

Takayanagi R., Inagami T., Snajdar R.M., Et al., Two distinct forms of receptors for atrial natriuretic factor in bovine adrenocortical cells, J Biol Chem, 262, pp. 12104-12113, (1987)

[9]

Olins G.M., Patton D.R., Bovy P.R., Mehta P.P., A linear analog of atrial natriuretic peptide (ANP) discriminates guanylate cyclase coupled ANP receptors from noncoupled receptors, J Biol Chem, 263, pp. 10989-10993, (1988)

[10]

Almeida F.M., Susuki M., Scarborough R., Et al., C-ANF receptors are specific binding sites in the metabolic clearance rate and modulation of plasma levels of ANF (abst), Second World Congress on Biologically Active Atrial Peptides, B58, (1987)

← 1 2 3 →